Why the study?
Is polypharmacy associated with duplicated therapy and contraindicated drug combinations in the elderly?
Is polypharmacy associated with duplicated therapy and contraindicated drug combinations in the elderly?
Polypharmacy in the elderly is associated with duplicated therapy and contraindicated drug combinations, highlighting the need for improved communication among healthcare providers and patients.
Supports careful prescribing review in elderly; cross-sectional data leaves open causality and intervention effects.
As shown by this study, polypharmacy was associated with duplicated therapy and contraindicated drug combinations. Improved communications among seniors, physicians, and pharmacists is necessary to minimize adverse consequences of polypharmacy.
No takes yet. Share an insight, caveat, or question.
Golchin et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: